Literature DB >> 23298585

PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties.

Manu M Joseph1, S R Aravind, Sheeja Varghese, S Mini, T T Sreelekha.   

Abstract

Polysaccharide PST001, which is isolated from the seed kernels of Tamarindus indica (Ti), is an antitumor and immunomodulatory compound. Gold nanoparticles have been used for various applications in cancer. In the present report, a novel strategy for the synthesis and stabilization of gold nanoparticles using anticancer polysaccharide PST001 was employed and the nanoparticles' antitumor activity was evaluated. PST-Gold nanoparticles were prepared such that PST001 acted both as a reducing agent and as a capping agent. PST-Gold nanoparticles showed high stability, no obvious aggregation for months and a wide range of pH tolerance. PST-Gold nanoparticles not only retained the antitumor effect of PST001 but also showed an enhanced effect even at a low concentration. It was also found that the nanoparticles exerted their antitumor effects through the induction of apoptosis. In vivo assays on BALB/c mice revealed that PST-Gold nanoparticles exhibited immunomodulatory effects. Evaluation of biochemical, hematological and histopathological features of mice revealed that PST-Gold nanoparticles could be administered safely without toxicity. Using the polysaccharide PST001 for the reduction and stabilization of gold nanoparticles does not introduce any environmental toxicity or biological hazards, and these particles are more effective than the parent polysaccharide. Further studies should be employed to exploit these particles as anticancer agents with imaging properties.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23298585     DOI: 10.1016/j.colsurfb.2012.11.046

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

1.  Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.

Authors:  Yichun Qian; Mantang Qiu; Qingquan Wu; Yanyan Tian; Yu Zhang; Ning Gu; Suyi Li; Lin Xu; Rong Yin
Journal:  Sci Rep       Date:  2014-12-15       Impact factor: 4.379

2.  Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.

Authors:  Manu M Joseph; S R Aravind; Suraj K George; Raveendran K Pillai; S Mini; T T Sreelekha
Journal:  Transl Oncol       Date:  2014-10-24       Impact factor: 4.243

3.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

4.  Design of an amphiphilic hyperbranched core/shell-type polymeric nanocarrier platform for drug delivery.

Authors:  Ayça Bal ÖztÜrk; Nesrin OĞuz; Hande Tekarslan Şahİn; Serkan Emİk; Emine AlarÇİn
Journal:  Turk J Chem       Date:  2020-04-01       Impact factor: 1.239

5.  The Immune-Enhancing Properties of Hwanglyeonhaedok-Tang-Mediated Biosynthesized Gold Nanoparticles in Macrophages and Splenocytes.

Authors:  Xiao-Jie Mi; Xing Yue Xu; Han Sol Choi; Hoon Kim; Ik Hyun Cho; Tae-Hoo Yi; Yeon-Ju Kim
Journal:  Int J Nanomedicine       Date:  2022-01-29

6.  Guanidine-Curcumin Complex-Loaded Amine-Functionalised Hollow Mesoporous Silica Nanoparticles for Breast Cancer Therapy.

Authors:  Thimma Mohan Viswanathan; Kaniraja Chitradevi; Azar Zochedh; Ramakrishnan Vijayabhaskar; Sureba Sukumaran; Selvaraj Kunjiappan; Nachimuthu Senthil Kumar; Krishnan Sundar; Ewa Babkiewicz; Piotr Maszczyk; Thandavarayan Kathiresan
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

Review 7.  Herb Polysaccharide-Based Drug Delivery System: Fabrication, Properties, and Applications for Immunotherapy.

Authors:  Yubiao Cao; Zhuowen Chen; Liangliang Sun; Yameng Lin; Ye Yang; Xiuming Cui; Chengxiao Wang
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.